TrianglePUBLICATIONS · 18477770
Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome-positive leukemia.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Blood
- Publication date
- 2008 Aug 15
- First author
- Porkka K
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Porkka K
- type
- Author
- name
- Koskenvesa P
- type
- Author
- name
- Lundán T
- type
- Author
- name
- Rimpiläinen J
- type
- Author
- name
- Mustjoki S
- type
- Author
- name
- Smykla R
- type
- Author
- name
- Wild R
- type
- Author
- name
- Luo R
- type
- Author
- name
- Arnan M
- type
- Author
- name
- Brethon B
- type
- Author
- name
- Eccersley L
- type
- Author
- name
- Hjorth-Hansen H
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Porkka K
- type
- Author
- name
- Koskenvesa P
- type
- Author
- name
- Lundán T
- type
- Author
- name
- Rimpiläinen J
- type
- Author
- name
- Mustjoki S
- type
- Author
- name
- Smykla R
- type
- Author
- name
- Wild R
- type
- Author
- name
- Luo R
- type
- Author
- name
- Arnan M
- type
- Author
- name
- Brethon B
- type
- Author
- name
- Eccersley L
- type
- Author
- name
- Hjorth-Hansen H
- type
- Author
- bibliography ids
- nci-bib-22f971355b6955d421540bff
- book metadata
- content sha256
- 9aa61e46085a2c956ed065bd8001960e5052b35206b2cac0d13bc765c3360a6f
- document type
- citation
- dois
- 10.1182/blood-2008-02-140665
- electronic publication date
- display
- 2008 May 13
- precision
- day
- year
- 2008
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:18477770
- immutable id
- pubmed:18477770@9aa61e46085a2c956ed065bd8001960e5052b35206b2cac0d13bc765c3360a6f
- journal
- abbreviation
- Blood
- issn electronic
- 1528-0020
- issn print
- 0006-4971
- issue
- 4
- name
- Blood
- nlm unique id
- 7603509
- pages
- 1005-12
- volume
- 112
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 18477770
- provenance
- batch id
- e663b4be92ee60a9b059
- provider
- NCBI PubMed ESummary
- record sha256
- d9aff0a3eff782bb3c7c89df825a8e17876a5092aec187a1a5783e4a53c54249
- response sha256
- 514286e846d1566a3f75c88a4af66b82adfc16ee2368b19bce657f2237aba90d
- retrieved at
- 2026-09-09T23:46:19.265979+00:00
- publication date
- display
- 2008 Aug 15
- precision
- day
- year
- 2008
- publication types
- Clinical Trial
- Journal Article
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome-positive leukemia.
Preserved source evidence · Not medical advice